Pharmaceuticals in hospital wastewater: Their ecotoxicity and contribution to the environmental hazard of the effluent

Chemosphere

Volumn 115, Issue 1, 2014, Pages 31-39

  Frédéric, Orias ^a   Yves, Perrodin ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Ecotoxicity; Hazard quotient; Hospital wastewater; Pharmaceuticals

Indexed keywords

DRUG PRODUCTS; HAZARDS; HOSPITALS; METABOLITES; RISK PERCEPTION; WASTEWATER TREATMENT;

AQUATIC ENVIRONMENTS; ECOTOXICITY; ENVIRONMENTAL HAZARDS; HAZARD QUOTIENTS; HOSPITAL WASTEWATER; PHARMACEUTICAL COMPOUNDS; PREDICTED NO-EFFECT CONCENTRATIONS; WASTEWATER TREATMENT PLANTS;

EFFLUENTS;

AMPICILLIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; AZITHROMYCIN; CHLORPROMAZINE; CINOXACIN; CLENBUTEROL; CLOTRIMAZOLE; DICLOFENAC; ESTRADIOL; ESTRONE; ETHINYLESTRADIOL; IMMUNOMODULATING AGENT; INSECT REPELLENT; INSECTICIDE; INSULIN DERIVATIVE; IOBITRIDOL; IOPAMIDOL; LETROZOLE; LIDOCAINE; LORATADINE; METHYLPREDNISOLONE; OFLOXACIN; PHENYLBUTAZONE; PROPYPHENAZONE; RITONAVIR; SULFAPYRIDINE; SULPIRIDE; TRICLOSAN; DANGEROUS GOODS; DRUG; WASTE WATER; WATER POLLUTANT;

CONCENTRATION (COMPOSITION); DRUG; ECOTOXICOLOGY; EFFLUENT; HAZARD; HOSPITAL SECTOR; METABOLITE; POLLUTANT SOURCE; WASTEWATER;

AQUATIC ENVIRONMENT; AQUATIC SPECIES; ARTICLE; ECOTOXICITY; EFFLUENT; HOSPITAL; METABOLITE; MUSCULOSKELETAL SYSTEM; POLLUTANT; RESPIRATORY SYSTEM; WASTE WATER; ANALYSIS; DANGEROUS GOODS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ECOTOXICOLOGY; ENVIRONMENTAL MONITORING; HUMAN; RISK ASSESSMENT; TOXICITY; WATER POLLUTANT;

DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ECOTOXICOLOGY; ENVIRONMENTAL MONITORING; HAZARDOUS SUBSTANCES; HOSPITALS; HUMANS; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84921670176     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2014.01.016     Document Type: Article

References (32)

1. Bantle J.A., Burton D.T., Dawson D.A., Dumont J.N., Finch R.A., Fort D.J., Linder G., Rayburn J.R., Buchwalter D., Gaudet-Hull A.M., Maurice M.A., Turley S.D. Fetax interlaboratory validation study: phase II testing. Environ. Toxicol. Chem. 1994, 13:1629-1637.
2. Besse J.-P., Garric J. Human pharmaceuticals in surface waters: implementation of a prioritization methodology and application to the French situation. Toxicol. Lett. 2008, 176:104-123.
3. Boillot C., Bazin C., Tissot-Guerraz F., Droguet J., Perraud M., Cetre J.C., Trepo D., Perrodin Y. Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities. Sci. Total Environ. 2008, 403:113-129.
4. DeYoung D.J., Bantle J.A., Hull M.A., Burks S.L. Differences in sensitivity to developmental toxicants as seen in xenopus and pimephales embryos. Bull. Environ. Contam. Toxicol. 1996, 56:143-150.
5. Emmanuel E., Keck G., Blanchard J.-M., Vermande P., Perrodin Y. Toxicological effects of disinfections using sodium hypochlorite on aquatic organisms and its contribution to AOX formation in hospital wastewater. Environ. Int. 2004, 30:891-900.
6. EPA ECOTOX database, 2013. (accessed 01.08.13).
7. Escher B.I., Fenner K. Recent advances in environmental risk assessment of transformation products. Environ. Sci. Technol. 2011, 45:3835-3847.
8. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res. 2011, 45:75-92.
9. Gibs J., Stackelberg P.E., Furlong E.T., Meyer M., Zaugg S.D., Lippincott R.L. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time. Sci. Total Environ. 2007, 373:240-249.
10. Gros M., Rodríguez-Mozaz S., Barceló D. Rapid analysis of multiclass antibiotic residues and some of their metabolites in hospital, urban wastewater and river water by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J. Chromatogr. A 2013, 1292:173-188.
11. Heath E., Kosjek T., Farre M., Quintana J.B., de Alencastro L.F., Castiglioni S., Gans O., Langford K., Loos R., Radjenović J., Rocca L.M., Budzinski H., Tsipi D., Petrovic M., Barcelo D. Second interlaboratory exercise on non-steroidal anti-inflammatory drug analysis in environmental aqueous samples. Talanta 2010, 81:1189-1196.
12. Heberer T. Tracking persistent pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
13. Jean J., Perrodin Y., Pivot C., Trepo D., Perraud M., Droguet J., Tissot-Guerraz F., Locher F. Identification and prioritization of bioaccumulable pharmaceutical substances discharged in hospital effluents. J. Environ. Manage. 2012, 103:113-121.
14. Joss A., Keller E., Alder A.C., Göbel A., McArdell C.S., Ternes T., Siegrist H. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res. 2005, 39:3139-3152.
15. Lajeunesse A., Gagnon C., Gagné F., Louis S., Čejka P., Sauvé S. Distribution of antidepressants and their metabolites in brook trout exposed to municipal wastewaters before and after ozone treatment - evidence of biological effects. Chemosphere 2011, 83:564-571.
16. Loos R., Locoro G., Comero S., Contini S., Schwesig D., Werres F., Balsaa P., Gans O., Weiss S., Blaha L., Bolchi M., Gawlik B.M. Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Res. 2010, 44:4115-4126.
17. Molander L., Ågerstrand M., Rudén C. WikiPharma - a freely available, easily accessible, interactive and comprehensive database for environmental effect data for pharmaceuticals. Regul. Toxicol. Pharmacol. 2009, 55:367-371.
18. Mullot J.-U., Karolak S., Fontana A., Levi Y. Modeling of hospital wastewater pollution by pharmaceuticals: first results of Mediflux study carried out in three French hospitals. Water Sci. Technol. 2010, 62:2912-2919.
19. Orias F., Perrodin Y. Characterisation of the ecotoxicity of hospital effluents: a review. Sci. Total Environ. 2013, 454-455:250-276.
20. Perrodin Y., Bazin C., Bony S., Devaux A., Bertrand-Krajewski J.-L., Cren-Olivé C., Roch A., Brelot E. A priori assessment of ecotoxicological risks linked to building a hospital. Chemosphere 2013, 90:1037-1046.
21. Sanderson H., Johnson D.J., Wilson C.J., Brain R.A., Solomon K.R. Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol. Lett. 2003, 144:383-395.
22. Silva B.F., Jelic A., López-Serna R., Mozeto A.A., Petrovic M., Barceló D. Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere 2011, 85:1331-1339.
23. Silva B.F.D., Jelic A., López-Serna R., Mozeto A.A., Petrovic M., Barceló D. Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere 2011, 85:1331-1339.
24. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Trace determination of tamoxifen and 5-fluorouracil in hospital and wastewaters. Int. J Environ. Anal. Chem. 2006, 86:473-485.
25. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
26. Verlicchi P., Galletti A., Petrovic M., Barceló D. Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J. Hydrol. 2010, 389:416-428.
27. Verlicchi P., Al Aukidy M., Galletti A., Petrovic M., Barceló D. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci. Total Environ. 2012, 430:109-118.
28. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci. Total Environ. 2012, 429:123-155.
29. Weissbrodt D., Kovalova L., Ort C., Pazhepurackel V., Moser R., Hollender J., Siegrist H., McArdell C.S. Mass flows of X-ray contrast media and cytostatics in hospital wastewater. Environ. Sci. Technol. 2009, 43:4810-4817.
30. WHO Collaborating Centre for Drug Statistics Methodology, 2011. Guidelines for ATC classification and DDD assignment. Oslo, 2010.
31. Yang Y., Fu J., Peng H., Hou L., Liu M., Zhou J.L. Occurrence and phase distribution of selected pharmaceuticals in the Yangtze estuary and its coastal zone. J. Hazard. Mater. 2011, 190:588-596.
32. Yuan S., Jiang X., Xia X., Zhang H., Zheng S. Detection, occurrence and fate of 22 psychiatric pharmaceuticals in psychiatric hospital and municipal wastewater treatment plants in Beijing, China. Chemosphere 2013, 90:2520-2525.